Lower middle- and low-income countries are less likely to receive market authorization for drugs that were trialed within their state and approved by the FDA within 5 years of approval when compared ...
The FDA approves generic dasatinib tablets, enhancing access and affordability for treating chronic myeloid leukemia and ...
Clinical Trials Arena on MSN
FDA unveils new pathway to usher bespoke therapies to market
The “plausible mechanism pathway” will allow personalised drugs to reach the market sooner for patients with genetic diseases ...
Poherdy is the first FDA-approved interchangeable biosimilar to Perjeta for HER2-positive breast cancer, potentially expanding access and reducing costs. Approved for use in combination with ...
Food and Drug Administration (FDA) Commissioner Marty Makary committed to reviewing the abortion drug mifepristone in a letter sent to Sen. Josh Hawley (R-Mo.). “As with all drugs, FDA continues to ...
The decision aims to improve access to HRT by removing warnings about cardiovascular disease, breast cancer, and probable dementia. HHS has initiated removal of black box warnings on hormone ...
WASHINGTON (AP) — Shortly before he was forced to resign, the nation’s top vaccine regulator says he refused to grant Health Secretary Robert F. Kennedy Jr.’s team unrestricted access to a tightly ...
U.S. regulators approved updated COVID-19 shots Wednesday but limited their use for many Americans - and removed one of the two vaccines available for young children. The new shots from Pfizer, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback